We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · March 26, 2020

The Omnipod Hybrid Closed-Loop System Improves Management in Adults, Adolescents, and Children With T1D

Diabetes Technology & Therapeutics


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Technology & Therapeutics
Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children With Type 1 Diabetes Over 5 Days Under Free-Living Conditions
Diabetes Technol. Ther. 2020 Mar 01;22(3)174-184, JL Sherr, BA Buckingham, GP Forlenza, A Galderisi, L Ekhlaspour, RP Wadwa, L Carria, L Hsu, C Berget, TA Peyser, JB Lee, J O'Connor, B Dumais, LM Huyett, JE Layne, TT Ly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.